Remicade Denied by Insurance?
How to Appeal & Get Approved
Generic: infliximab
The original infliximab — now almost always denied in favor of cheaper biosimilars.
- Used for
- Psoriasis, Crohn's, UC, RA, Ankylosing Spondylitis
- Route
- IV
- Specialty
- Dermatology
- PA Required
- Yes — 93% of prescriptions
Common Denial Reasons
Remicade is frequently denied for step therapy, documentation, and formulary reasons. Decode your specific denial →
require prior authorization before your pharmacy can fill them. If you've been denied, you're not alone — and most denials can be overturned on appeal.
Step Therapy Requirements
"Fail first" — what insurers require before approving Remicade
Most insurers require you to try alternative medications before approving Remicade. See your insurer's requirements →
Let Ellen Fight Your Remicade Denial
Ellen generates a personalized appeal letter for Remicade using your denial reason, insurer, and clinical situation.
- ✓Instant denial decoding — understand why you were denied
- ✓Payer-specific appeal language that matches your insurer's criteria
- ✓Clinical evidence suggestions your doctor can use
Insurance Coverage
Ellen tracks Remicade coverage across 12+ major insurers including formulary status, step therapy requirements, and common denial patterns.
Check your insurer's Remicadepolicy →Safety Information
From FDA-approved prescribing information for Remicade (TNF Inhibitor)
Serious infections (TB, invasive fungal), malignancies including lymphoma, hepatosplenic T-cell lymphoma
Do Not Use If
- ✕Active serious infections including sepsis
- ✕Active tuberculosis
- ✕Heart failure (NYHA III/IV) at doses >5mg/kg
- ✕Clinically significant hypersensitivity to infliximab or murine proteins
Key Warnings
- ⚠Screen for TB and hepatitis B before starting
- ⚠Infusion reactions — premedicate if history of reactions
- ⚠Do not use with other biologics
This is not a complete list. See the full Remicade prescribing information or ask your pharmacist for comprehensive safety data.
Frequently Asked Questions
›Can I still get brand Remicade?
It's increasingly difficult. Most insurers now require biosimilar infliximab (Avsola, Inflectra, or Renflexis) over brand Remicade. If you're currently stable on brand Remicade, your doctor can appeal based on treatment continuity and anti-drug antibody risk from switching.
›Are Remicade biosimilars the same as Remicade?
Biosimilars are highly similar to the reference product with no clinically meaningful differences. However, some patients and doctors have concerns about switching mid-treatment. If you experience issues after a switch, document them for a potential appeal back to brand.
›What's a site-of-care restriction for Remicade?
Some insurers require infliximab infusions at the lowest-cost setting — typically a home infusion service or ambulatory infusion center rather than a hospital outpatient facility. Your doctor can appeal if hospital-based infusion is medically necessary.